185 related articles for article (PubMed ID: 31425707)
1. Environmental Exposures Such as Smoking and Low Vitamin D Are Predictive of Poor Outcome in Cutaneous Melanoma rather than Other Deprivation Measures.
Hardie CM; Elliott F; Chan M; Rogers Z; Bishop DT; Newton-Bishop JA
J Invest Dermatol; 2020 Feb; 140(2):327-337.e2. PubMed ID: 31425707
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness.
Wyatt C; Lucas RM; Hurst C; Kimlin MG
PLoS One; 2015; 10(5):e0126394. PubMed ID: 25970336
[TBL] [Abstract][Full Text] [Related]
3. A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival.
Stenehjem JS; Grimsrud TK; Rees JR; Vos L; Babigumira R; Veierød MB; Robsahm TE
BMJ Open; 2017 Jun; 7(6):e014829. PubMed ID: 28637727
[TBL] [Abstract][Full Text] [Related]
4. Severe vitamin D deficiency associated with BRAF-mutated melanoma.
Fearfield L; Nobbs J; Petruckevitch A; Harland C
Br J Dermatol; 2019 Dec; 181(6):1343. PubMed ID: 31381132
[No Abstract] [Full Text] [Related]
5. Re: Sun exposure and mortality from melanoma.
Kalish RS
J Natl Cancer Inst; 2005 Aug; 97(15):1158; author reply 1159-62. PubMed ID: 16077076
[No Abstract] [Full Text] [Related]
6. Low socio-economic status is a newly identified independent risk factor for poor vitamin D status in severely obese adults.
Léger-Guist'hau J; Domingues-Faria C; Miolanne M; Peyrol F; Gerbaud L; Perreira B; Minet-Quinard R; Sapin V; Walrand S; Boirie Y
J Hum Nutr Diet; 2017 Apr; 30(2):203-215. PubMed ID: 27524803
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features, vitamin D serological levels and prognosis in cutaneous melanoma of shield-sites: an update.
Paolino G; Moliterni E; Didona D; Garelli V; Corsetti P; Lopez T; Richetta AG; Cantisani C; Bottoni U; Calvieri S
Med Oncol; 2015 Jan; 32(1):451. PubMed ID: 25516505
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D-VDR Signaling Inhibits Wnt/β-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity.
Muralidhar S; Filia A; Nsengimana J; Poźniak J; O'Shea SJ; Diaz JM; Harland M; Randerson-Moor JA; Reichrath J; Laye JP; van der Weyden L; Adams DJ; Bishop DT; Newton-Bishop J
Cancer Res; 2019 Dec; 79(23):5986-5998. PubMed ID: 31690667
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma.
Timerman D; McEnery-Stonelake M; Joyce CJ; Nambudiri VE; Hodi FS; Claus EB; Ibrahim N; Lin JY
Oncotarget; 2017 Jan; 8(4):6873-6882. PubMed ID: 28036288
[TBL] [Abstract][Full Text] [Related]
10. 25-Hydroxyvitamin D2 /D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort.
Newton-Bishop JA; Davies JR; Latheef F; Randerson-Moor J; Chan M; Gascoyne J; Waseem S; Haynes S; O'Donovan C; Bishop DT
Int J Cancer; 2015 Jun; 136(12):2890-9. PubMed ID: 25403087
[TBL] [Abstract][Full Text] [Related]
11. 25-Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies.
Cattaruzza MS; Pisani D; Fidanza L; Gandini S; Marmo G; Narcisi A; Bartolazzi A; Carlesimo M
Eur J Cancer Prev; 2019 May; 28(3):203-211. PubMed ID: 29438161
[TBL] [Abstract][Full Text] [Related]
12. Can UV exposure reduce mortality?
Berwick M
Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):582-4. PubMed ID: 21454422
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.
De Smedt J; Van Kelst S; Boecxstaens V; Stas M; Bogaerts K; Vanderschueren D; Aura C; Vandenberghe K; Lambrechts D; Wolter P; Bechter O; Nikkels A; Strobbe T; Emri G; Marasigan V; Garmyn M
BMC Cancer; 2017 Aug; 17(1):562. PubMed ID: 28835228
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D status in apparently healthy medication-free Slovaks: Association to blood pressure, body mass index, self-reported smoking status and physical activity.
Sebekova K; Krivosikova Z; Gajdos M; Podracka L
Bratisl Lek Listy; 2016; 117(12):702-709. PubMed ID: 28127966
[TBL] [Abstract][Full Text] [Related]
15. No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival.
Luo L; Orlow I; Kanetsky PA; Thomas NE; Fang S; Lee JE; Berwick M; Lee JH;
PLoS One; 2017; 12(3):e0174234. PubMed ID: 28323902
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with vitamin D deficiency in a Norwegian population: the HUNT Study.
Larose TL; Chen Y; Camargo CA; Langhammer A; Romundstad P; Mai XM
J Epidemiol Community Health; 2014 Feb; 68(2):165-70. PubMed ID: 24197920
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and melanoma incidence and mortality.
Berwick M; Erdei EO
Pigment Cell Melanoma Res; 2013 Jan; 26(1):9-15. PubMed ID: 22947439
[TBL] [Abstract][Full Text] [Related]
18. Nodular Type but Not Vitamin D Levels Increases the Risk of Second Primary Cancers in Melanoma Patients: An Observational Study of 663 Patients.
Massa A; Isasi-Fuster A; Requena C; Manrique-Silva E; Kumar R; Nagore E
Actas Dermosifiliogr; 2024 Feb; 115(2):T143-T149. PubMed ID: 38048949
[TBL] [Abstract][Full Text] [Related]
19. Nodular type but not vitamin D levels increases the risk of second primary cancers in melanoma patients: An observational study of 663 patients.
Massa A; Isasi-Fuster A; Requena C; Manrique-Silva E; Kumar R; Nagore E
Actas Dermosifiliogr; 2024 Feb; 115(2):143-149. PubMed ID: 37832865
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D in treated melanoma patients on follow up.
MacKie RM
Br J Dermatol; 2010 Mar; 162(3):697. PubMed ID: 20030636
[No Abstract] [Full Text] [Related]
[Next] [New Search]
